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Cytochrome P450 (CYP) enzymes for which there is no functional information
are considered “orphan” CYPs. Previous studies showed that CYP20A1, an
orphan, is expressed in human hippocampus and substantia nigra, and in
zebrafish (Danio rerio) CYP20A1 maternal transcript occurs in eggs, suggesting
involvement in brain and in early development.Moreover, hyperactivity is reported
in humanswith chromosome 2 microdeletions including CYP20A1. We examined
CYP20A1 in zebrafish, including impacts of chemical exposure on expression.
Zebrafish CYP20A1 cDNAwas cloned, sequenced, and alignedwith cloned
human CYP20A1 and predicted vertebrate orthologs. CYP20A1s share a highly
conserved N-terminal region and unusual sequences in the I-helix and the heme-
binding CYP signature motifs. CYP20A1 mRNA expression was observed in adult
zebrafish organs including the liver, heart, gonads, spleen and brain, as well as
the eye and optic nerve. Putative binding sites in proximal promoter regions of
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Cytochrome P450 (CYP) enzymes for which there is no functional information are considered “orphan” CYPs.
Previous studies showed that CYP20A1, an orphan, is expressed in human hippocampus and substantia nigra,
and in zebraﬁsh (Danio rerio) CYP20A1maternal transcript occurs in eggs, suggesting involvement in brain and
in early development.Moreover, hyperactivity is reported in humanswith chromosome2microdeletions includ-
ing CYP20A1. We examined CYP20A1 in zebraﬁsh, including impacts of chemical exposure on expression.
Zebraﬁsh CYP20A1 cDNAwas cloned, sequenced, and aligned with cloned human CYP20A1 and predicted verte-
brate orthologs. CYP20A1s share a highly conserved N-terminal region and unusual sequences in the I-helix and
the heme-binding CYP signature motifs. CYP20A1mRNA expression was observed in adult zebraﬁsh organs in-
cluding the liver, heart, gonads, spleen and brain, as well as the eye and optic nerve. Putative binding sites in
proximal promoter regions of CYP20A1s, and response of zebraﬁsh CYP20A1 to selected nuclear and xenobiotic
receptor agonists, point to up-regulation by agents involved in steroid hormone response, cholesterol and lipid
metabolism. There also was a dose-dependent reduction of CYP20A1 expression in embryos exposed to environ-
mentally relevant levels of methylmercury. Morpholino knockdown of CYP20A1 in developing zebraﬁsh resulted
in behavioral effects, including hyperactivity and a slowing of the optomotor response in larvae. The results sug-
gest that altered expression of CYP20A1might be part of a mechanism linking methylmercury exposure to neu-
robehavioral deﬁcits. The expanded information on CYP20A1 brings us closer to “deorphanization”, that is,
identifying CYP20A1 functions and its roles in health and disease.







In animals, enzymes of the cytochrome P450 (CYP) superfamily
(Nelson, 2009) catalyze oxidation reactions as well as reductions and
rearrangements with a vast array of endogenous and exogenous
compounds, often with high regio- and stereo-selectivity (Lamb and
Waterman, 2013). These activities serve a wide range of physiological
and toxicological functions. In vertebrate genomes, the number of
protein-coding CYP genes range from around 40 to more than 100, in
19 gene families (Nelson et al., 2013). While functions are known for
many human CYPs, the physiological substrate(s) and function of a
substantial number of vertebrate CYPs remain unknown. In humans,
these so-called “orphan P450s” notably include CYP4F22, CYP4V2
and CYP20A1 (Stark and Guengerich, 2007). In the model species
zebraﬁsh (Danio rerio), there are few CYPs for which function has
been shown. Functions can be inferred for many CYPs in gene fami-
lies 5–51, based on activities of known mammalian orthologs, yet
predicted function has been conﬁrmed in few cases (e.g., the
lanosterol 14α-demethylase CYP51) (Morrison et al., 2014). In
gene families 1–3, there has been much lineage speciﬁc expansion,
resulting in co-orthologs, most with unknown function (Kubota
et al., 2013). Thus, many zebraﬁsh CYPs still are properly considered
orphans, including CYP20A1.
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The sole member of the CYP20 family, CYP20A1, is found in a single
copy in human, zebraﬁsh and other vertebrate genomes sequenced
to date. The catalytic function of CYP20A1 is unknown. Recombinant
human CYP20A1 has been tested for activity (Stark et al., 2008), how-
ever, no oxidation reaction was detected with several endogenous
compounds (steroids, fatty acids, neurotransmitters) or exogenous
chemicals (i.e., terfenadine, clotrimazole) that are substrates for some
other CYPs. Although limited information is available on this orphan
P450, it was found to be relatively highly expressed in human hippo-
campus and substantia nigra (Stark et al., 2008). These two brain re-
gions are associated with learning and memory, and are involved in
neurodegenerative diseases (Wirdefeldt et al., 2011; Zhou et al.,
2008). High levels of CYP20A1 transcript occur also in unfertilized eggs
(Goldstone et al., 2010) and in notochord (Thisse and Thisse, 2004) of
developing zebraﬁsh, and during embryonic development of mouse
(Choudhary et al., 2003).
An important observation derives from conditions associated with a
microdeletion on chromosome 2 in humans. Patients diagnosed with
microdeletions in the2q33 chromosome regionwhere CYP20A1 is locat-
ed variously show psychomotor retardation, hyperactivity and bouts of
anxiety, among other conditions (Balasubramanian et al., 2011;
Tomaszewska et al., 2013). The observations together suggest participa-
tion of CYP20A1 early in vertebrate development, and possible involve-
ment in brain functions and behavior. However, these possibilities have
not been examined experimentally.
In the present study, we employed zebraﬁsh to examine features of
CYP20A1 that could bear on its functions. Zebraﬁsh CYP20A1was cloned
and sequenced, and the inferred primary structure was compared to
that of the cloned human enzyme, and to CYP20A1 coding sequences
found in vertebrate genomes. We determined the organ distribution
of transcript in adult zebraﬁsh, and analyzed the transcriptional re-
sponses to agonists for several nuclear receptors and the aryl hydrocar-
bon receptor (AHR) that are prominent in regulating expression of a
number of CYP genes in vertebrates (Honkakoski and Negishi, 2000).
The latter analysis was complemented by a search for putative binding
sites recurring in proximal promoters of vertebrate CYP20A1 genes.
We also conducted studies of CYP20A1 mRNA expression in zebraﬁsh
embryos with the potent environmental toxicant methylmercury
(MeHg). Finally, early-developing zebraﬁsh were screened for morpho-
logical and behavioral effects resulting from knockdown of CYP20A1 ex-
pression using morpholine-substituted oligonucleotides. The results
together provide new information and perspective on the regulation
and function of CYP20A1, including possible involvement in neurobe-
havioral disorders, and the effects of chemicals linked to such disorders.
2. Material and methods
2.1. Animals
Experiments were conducted on early-developing and sexually
mature zebraﬁsh (Danio rerio) of the Tupfel Long-ﬁn (TL), Tropical 5D
and AB strains, and were approved by the Animal Care and Use Commit-
tee of theWoods Hole Oceanographic Institution, Oregon State University
andUniversite Catholique de Louvain, respectively. The associatedAnimal
Welfare Assurance Numbers are respectively A3630-01, A3229-01
and 1458701. Fish were euthanized by immersion in a bath of tricaine
methanesulfonate (MS-222). Fish maintenance and breeding procedures
were previously described (Jonsson et al., 2007a, 2007b).
2.2. cDNA cloning and sequencing
Primers were designed in the proximal 5′ and 3′ untranslated re-
gions of zebraﬁsh CYP20A1 transcript [GenBank: NM_213332.1]. Primer
sequences were 5′-CTGATGGTCATTGTAGACG-3′ (F) and 5′-TCATGGAT
GTTGGAGTGG-3′ (R). We used the Advantage 2 PCR kit from Clontech
(Mountain View, USA) to amplify the coding sequence fromTL zebraﬁsh
liver cDNAwith 1 μM of each primer; the thermal proﬁle was: 94 °C for
1 min, [94 °C for 30 s, 58 °C for 3 min] for 35 cycles, and 68 °C for 7 min.
PCR products were puriﬁed with the QIAquick Gel Extraction Kit from
Qiagen (Valencia, USA) and cloned into pGEM-T Easy from Promega
(Madison, USA) as per kit instructions. Mach-1 competent cells from
Invitrogen (Carlsbad, USA) were transformed, and, following overnight
incubation of selected ampicillin-resistant white colonies in liquid
Luria-Bertani medium with antibiotic, plasmids were isolated with the
QIAprep Spin Miniprep Kit from Qiagen (Valencia, USA). Three clones
were sent to Euroﬁns MWG Operon (Louisville, USA) for forward and
reverse sequencing with T7 primers (1 μg of plasmid DNA), and the
full-length sequence was then assembled and aligned with [GenBank:
NM_213332.1] using MacVector 12.0.2 (Oxford Molecular Group,
Madison, USA).
2.3. Secondary structure prediction
Amino acid sequences of CYP20A1 proteins were retrieved from the
Ensembl database (Flicek et al., 2013) and aligned with MacVector
12.0.2 software (Oxford Molecular Group, USA) (see Supplemental
Fig. S1 for sequence identiﬁers). Note that the protein sequence inferred
from the TL zebraﬁsh transcript we cloned was fully identical to that
predicted from the genome [Ensembl: ENSDARP00000003222].
The speciﬁc motifs of CYP20A1 secondary structure (i.e. α-helices, β-
strands, transmembrane domain, signal peptide) were predicted with
two different online softwares, and overlapping predictions were cho-
sen to construct the consensual secondary structure of the orphan
P450. The α-helices were predicted with NetSurfP 1.1 (Petersen et al.,
2009) and Psipred 3.0 (Bryson et al., 2005) at a cut-off of 80%. Putative
β strands were localized with PredictProtein (Rost et al., 2004) and
BETApro (Cheng and Baldi, 2005) under default settings. Hypothetical
transmembrane domains were identiﬁed with PredictProtein (Rost
et al., 2004) and TMHMM 2.0 (Krogh et al., 2001) at a cut-off of 80%.
The possible presence of a signal peptide in the N-terminal portion of
CYP20A1 was investigated with pSORTII (Nakai and Horton, 1999)
and SignalP 4.1 (Petersen et al., 2011) under default settings. The loca-
tions of the P450 signature motifs (i.e., I-helix, K helix and heme-
binding region)were analyzed based on the information available in re-
views (Sezutsu et al., 2013;Werck-Reichhart and Feyereisen, 2000). The
motifs speciﬁc to zebraﬁsh and human CYP20A1 protein alsowere com-
pared to those of all other zebraﬁsh and human protein-coding CYPs
available in the Ensembl database (data not shown). A subset of the
zebraﬁsh CYPswas used as a basis for the comparison of CYP20A1 signa-
ture motifs shown in Table 1. The sequence identiﬁers for the selected
non-CYP20 isoforms are shown in Supplemental Table S6.
Table 1









CYP20A1 AGCVIT ETVR F-SGSQACPE
CYP1A AGFDTI EIFR FGLGKRRCIG
CYP2AA2 AGTDTT EIQR FSLGPRACLG
CYP3C1 GGYETT ESMR FGLGPRNCIG
CYP5A1 AGYETS ESLR FGAGPRSCVG
CYP7A1 ASQGNT EAMR FGSGVTKCPG
CYP7C1 ASVGNT ESLR FGSGATQCPG
CYP8A1 VTQGNA ETLR WGTEDNLCPG
CYP8B1 ASQGNT ETLR WGAGTTMCPG
CYP8B2 ASQGNT ETLR WGAGTTMCPG
CYP8B3 ASQGNT ETLR WGAGTTMCPG
CYP11C1 GGVDTT ETLR FGFGSRQCVG
CYP39A1 ASLANA EAIR FGGGKNQCPG
CYP51 AGQHTS ETLR FGAGRHRCIG
Underlined residues in some CYP isoforms (including CYP20A1) are those differing from
the classical P450 signature motif reported in the heading of each column. See sources
in Table S6.
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2.4. CYP20A1 heterologous protein expression
Zebraﬁsh CYP20A1 was heterologously expressed in Escherichia coli,
using similar methodology described for other eukaryotic P450s
(Barnes et al., 1991). In essence, expression was obtained by replacing
the putativemembrane anchorN-terminal regionwith amembrane an-
chor from Bos taurus CYP17A1. Preparation of the samples and spectro-
photometric analysis of the reduced, CO-ligated protein was done as
before (Morrison et al., 2014).
2.5. In silico promoter analysis
The proximal promoter regions of CYP20A1s from the zebraﬁsh, frog
(Xenopus tropicalis), chicken (Gallus gallus), rat (Rattus rattus) and
humanwere screened to identify putative binding sites for transcription
factors (TFs) possibly involved in regulation of the orphan P450. Infor-
mation on gene sequence was retrieved from the Ensembl database
(Flicek et al., 2013). However, in the case of X. tropicalis, we used as-
sembly 7.1 from the Joint Genome Institute available through
Xenbase (James-Zorn et al., 2013). A region of 10 kb upstream of
the start codon was selected for analysis with MatInspector soft-
ware (Cartharius et al., 2005). The 10 kb proximal promoter regions
of vertebrate CYP20A1 genes were searched with MatInspector for
putative binding sites having either 100% core sequence identity to
known human TF binding sites, or a less stringent 80% core sequence
identity. The putative TF binding sites that occurred in common in
the different species' CYP20A1s were classiﬁed in two groups, one
for nuclear receptor TFs and the other for non-nuclear receptor
TFs. Data for the latter group were subjected to an additional analy-
sis. That is, the Uniprot database (Bairoch et al., 2005) was interro-
gated to identify recurring gene ontology terms in the pool of
these recurring non-nuclear receptor TFs. Gene ontology informa-
tion was retrieved for rat and human TFs whenever possible. The da-
tabase generated was interrogated to identify the cell types,
biological systems and processes over-represented in this pool of
non-nuclear receptor TFs.
2.6. Organ distribution
Transcript abundancewas analyzed in various organs of TL zebraﬁsh
by means of quantitative real-time PCR (qPCR), using liver as a refer-
ence tissue. The protocol of ﬁsh dissection followed that of Gupta &
Mullins (Gupta and Mullins, 2010), using MS-222 for euthanasia. For
the ﬁrst set of samples, 12 males and 12 females were dissected to ob-
tain the liver, intestine, gonad, heart, kidney, whole brain and eye; or-
gans were pooled from four males and from four females, giving three
pools for each sex. Statistical analyses were conducted on tissues of
males and females separately. For the second set, 12 males were dis-
sected and tissues pooled to obtain three pools each of liver, spleen,
forebrain, midbrain, hindbrain and optic nerve. All samples were
ﬂash-frozen in liquid nitrogen upon collection and stored at
−70 °C until processing. RNA was extracted with the Aurum Total
Fatty and Fibrous Tissue kit from Bio-Rad (Hercules, USA) as per
kit instructions. Total RNA was quantiﬁed by spectrophotometry
and purity checked with a Nanodrop ND-1000 (Wilmington, USA)
at OD260/280 and OD260/230. Reverse transcription of 1 μg (ﬁrst set)
or 150 ng (second set) of total RNA was done with the iScript
cDNA Synthesis kit from Bio-Rad, as per kit instructions. QPCR
were run on a MyIQ single-color real-time thermocycler with IQ
Sybr green Supermix from Bio-Rad. The E−ΔΔCt method was used
for relative quantiﬁcation (Livak and Schmittgen, 2001), using the
geometric mean of aryl hydrocarbon receptor nuclear translocator
2 (arnt2) and elongation factor 1 alpha (ef1α) Ct values for normal-
ization (Kubota et al., 2013; Morrison et al., 2014). Primers were: 5′-
TACAGGAGGTGGAAGGAAAGGTG-3′ (F) and 5′-GACGACCACCAAGG
GCATAGATAAC-3′ (R) for CYP20A1.
2.7. Exposure to nuclear and cytosolic receptor agonists, and methylmercury
Experimental exposures of zebraﬁsh to selected nuclear and xenobi-
otic receptor agonists were conducted on pools of 15 TL embryos, in
60ml of 0.3×Danieau's solution. Exposures began at 24 h post-fertiliza-
tion (hpf), and lasted 24 h (up to 48 hpf) or 48 h (up to 72 hpf). Tested
chemicals in solvent carrier (dimethylsulfoxide or ethanol) or solvent
carrier alone were added at a ﬁnal volume of 0.1%. Supplemental
Table S2 provides a list of the tested chemicals and their known action
on nuclear or xenobiotic receptors in mammals and zebraﬁsh, to the
best of our knowledge. Ethanol was used as solvent only for exposures
to α-tocopherol, arachidonic, docosahexaenoic and eicosapentaenoic
acids. Exposures to photosensitive agonists were conducted for 24 h at
nominal concentrations of 0.1–1–10 μM. Other exposures were con-
ducted for 48 h at 0.1–1–3.2 μM, except that PCB 126 was tested for
48 h at doses (1–10–32 nM) that elicit CYP1 induction in zebraﬁshwith-
out compromising viability (Jonsson et al., 2007a, 2007b). All chemicals
were of ≥95% purity. Following incubations, TL embryos were quickly
washed with 0.3× Danieau's solution, frozen in liquid nitrogen and
stored at−70 °C until RNA extraction. Sample preparation and qPCR
analysis were the same as used in the tissue distribution analysis, except
that extraction was performed with Aurum Total RNAMini kit. One mi-
crogram of total RNA was used for reverse transcription.
Experimental exposures of zebraﬁsh to methylmercury (MeHg)
chloride were conducted on pools of 15 AB embryos, in 60 ml of 1×
E3 medium, at the Institute of Life Sciences (Universite Catholique de
Louvain). Exposure to 10 and 50 μg l−1 MeHg began at 24 hpf and em-
bryos were sampled at 48 hpf, a protocol that does not result in embryo
mortality (Hassan et al., 2012). Solvent carrier was distilled water (0.1%
ﬁnal volume). Following incubations, AB embryoswerewashedwith E3
medium, frozen in liquid nitrogen and stored at−70 °C until RNA ex-
traction. We used the exact same procedure of RNA extraction and
cDNA synthesis as for TL embryos above. The qPCR experiments were
run on a StepOne Plus real-time thermocycler with SYBR Select Master
Mix, both from Applied Biosystems. We conﬁrmed that this change of
qPCR protocol did not affect the speciﬁcity or efﬁciency of ampliﬁcation
using the same reference genes andmethod of relative quantiﬁcation as
in TL exposure studies above.
2.8. Morpholino-based CYP20A1 knockdown
Fertilized zebraﬁsh eggs were injected at the 2- to 4-cell stages with
ﬂuorescein-tagged morpholino oligonucleotides (MO) from Gene Tools
(Philomath, USA), complementary to a region encompassing the CYP20A1
start codon (5′-AATCTAGCATTTTTGCTTTTCAGGGA-3′). Morpholino
knockdown is transient but effects can persist to 5 or more days
post-fertilization. Controls for the speciﬁcity of gene knockdown
consisted of embryos injected with a control MO (5′-CCTCTTACCT
CAGTTACAATTTATA-3′), and non-injected embryos. Hence, three
groups were deﬁned for phenotyping studies, non-injected, control
MO-injected, and CYP20A1 MO-injected ﬁsh. Microinjection of
2.1 nl of 0.18 mM MO followed the protocol previously described
(Jonsson et al., 2007a). The efﬁcacy of CYP20A1 MO to block transla-
tion of the CYP20A1 was veriﬁed by inhibition of in vitro protein
synthesis with a TnT assay from Promega (the inhibition of in vitro
synthesis was about 50%; see Supplemental Fig. S2). We used only
those embryos showing high-level ﬂuorescence at 24 hpf, indicating
abundant MO in the embryo.
For the Optomotor and Movement Tracking behavioral studies with
the TL strain (described below), larvae were taken from each separate
clutch or batch of TL zebraﬁsh and distributed into three groups
(i.e., in non-injected, control MO-injected, and CYP20A1 MO-injected
groups), with 30 individuals in each group. Initially, early-developing
zebraﬁsh were kept in 0.3× Danieau's solution for 3 days and 72 hpf
embryos were then transferred in system water. Larvae from each
group were fed once at 4 days post-fertilization (dpf) with a mixture
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of spirulina and 30-μm Hathchfry Encapsulon diet from Argent
(Redmond, USA). Behavior assays were conducted at 5 dpf. TL ﬁsh in
the various groupswere examined daily bymicroscopy for anymorpho-
logical abnormalities.
2.9. Optomotor assay
Six separate clutches or batches of TL zebraﬁsh larvae were used to
study the optomotor response (OMR). With each batch, OMR was
assessed on 20 larvae from each of the non-injected, control MO-
injected, and CYP20A1MO-injected groups. The 20 larvaewere random-
ly selected from the 30 larvae in each group. A transparent test chamber
(25 cm long), placed on top of a computer monitor, was ﬁlled with sys-
temwater at 26.5± 1.5 °C. A pattern of black andwhite stripes, moving
with a period of 6.5 cm and a frequency of 0.5 Hz, was displayed on the
monitor. Larvae were assayed individually. Since zebraﬁsh respond to
low spatial frequencies by low velocities of optomotor response
(Maaswinkel and Li, 2003), individuals were tested over 1-min periods
and distances travelledwere recorded every 15 s. Therewere no signs of
aliasing under these conditions, and the responsiveness and distance
travelled by control larvae were not signiﬁcantly increased when the
frequency of wave motion was doubled (data not shown). All trials
were conducted between 3:00 and 7:00 PM, and larvae from one group
were tested before those from the other twogroups. To rule out a possible
effect of time on the optomotor responses, three batches were tested,
with thenon-injected controls testedﬁrst and theCYP20A1MOﬁsh tested
last, and three others were conducted in the reverse order. Similar pat-
terns of OMR were observed in all experiments.
2.10. Movement tracking and activity quantitation
Behavioral studies were also conducted with TL zebraﬁsh, using
an automated video tracking system from ViewPoint Life Sciences
(Montreal, Canada). For each experimental group (i.e., non-injected,
control MO-injected, and CYP20A1 MO-injected), 8 larvae were ran-
domly selected from among the 10 individuals that were not tested in
the OMR assay. These larvae were transferred individually in the wells
of a 24-well plate ﬁlled with 2 ml of system water (26.5 ± 1.5 °C).
Motion and activity were recorded in consecutive 10-min videos
under white light illumination. The ﬁrst session (tracking) was started
5 min after larvae were introduced in the plate. The second session
(activity) was started 5 min after completion of the ﬁrst recording. For
the tracking experiment, thresholds were: 0.5 cm·s−1 for large move-
ment and 0.1 cm·s−1 for inactivity. For activity analysis, thresholds
were 10 pixels per frame for burst and 1 for freeze.
2.11. High-throughput morphological assessment and photomotor
response
As noted above, analysis of the CYP20A1-MO effects on TL strain ﬁsh
included a daily microscopic monitoring of morphology. We also ad-
dressed morphological phenotypes using a high-throughput approach,
conducted at 24 hpf (1 day) and 120 hpf (5 days) on non-injected, con-
trol MO-injected and CYP20A1MO-injected Tropical 5D strain zebraﬁsh
at the Department of Environmental and Molecular Toxicology, Oregon
State University. For this study, at 4 h post-fertilization (hpf) chorions
were removed enzymatically with pronase, and embryos individually
transferred to the wells of a 96-well plate with 100 μl of embryo medi-
um at 28 °C. Plates were sealed and protected from light for up to 120
hpf (Truong et al., 2014). Tropical 5D zebraﬁsh from each of the three
experimental groups also were assessed at 24 hpf for photomotor
response according to previously published procedures (Truong et al.,
2014).
2.12. Statistical analyses
Statistical analyses for results obtained with the TL and AB strains
were conducted at the α= 0.05 level of signiﬁcance with the Statistica
7.1 package from Statsoft (Tulsa, USA). Data were tested for normality
by Kolmogorov–Smirnov test, and for homoscedasticity by Levene's
test. Since multiple independent experiments were necessary to inves-
tigate CYP20A1 expression at all doses of each chemical in exposure
studies (except for MeHg), qPCR data were compared by two-tailed
Student's t-test with batch-speciﬁc solvent controls. The MeHg dose–
response data were analyzed by one-way ANOVA followed by post hoc
LSD Fisher's test. The non-parametric Kruskal–Wallis ANOVA, followed
by Z-adjusted Mann–Whitney U test, was used for statistical analyses
of the tissue distribution and OMR studies. Data for movement tracking
and activity quantitation of TL larvaewere analyzed by one-way ANOVA
followed by post-hoc LSD Fisher's test. Results were expressed either as
mean ± SEM or mean ± SD, and graphs generated with Sigma Plot 8.0
software from Systat (San Jose, USA). Statistical analyses for resultswith
Tropical 5D ﬁsh were conducted as before (Truong et al., 2014).
3. Results
3.1. Cloning and sequence analysis of zebraﬁsh CYP20A1
Primers designed to the proximal 5′ and 3′ untranslated regions of
zebraﬁsh CYP20A1 transcript were used to amplify a full-length coding
sequence from the Tupfel Long-ﬁn (TL) strain. A protocol with a low an-
nealing temperaturewas selected to ensure that possible strain-speciﬁc
polymorphism in the untranslated regions did not impede primer
binding and PCR efﬁciency. A bright band of the expected size was
obtained, and results of sequencing revealed that the transcript
from the TL strain was fully identical to the cDNA sequence of
zebraﬁsh CYP20A1 available in various databases (GenBank: NM_
213332.1; Ensembl: ENSDART00000019325). The inferred amino
acid sequence of our cloned zebraﬁsh CYP20A1 shares sequence
identities ranging from 59 to 66% with CYP20A1 found in genomes
of tetrapods, and from 69 to 82% with CYP20A1 from genomes of
other ﬁshes (Supplemental Table S1). Such percentages were to be
expected for members of a given vertebrate P450 subfamily.
3.2. Sequence structure and P450 signature motifs
The amino acid sequences derived from the cloned zebraﬁsh and the
cloned human CYP20A1s (Stark et al., 2008) are aligned in Fig. 1. Fea-
tures of protein structure that are alpha-helices (n= 13), beta strands
(n = 8) and P450 signature motifs (n = 3; see Table 1 headings)
were identiﬁed based on alignment with other protein-coding CYPs
from human and in silico predictions. As shown in Fig. 1, a conserved
N-terminal segment of about 30 residues that comprises a transmem-
brane domain typical of microsomal P450s is found in human and
zebraﬁsh CYP20A1s. A signal peptide -perhaps targeting the protein to
mitochondria- is also predicted to occur, just after the transmembrane
domain. P450 signature motifs are identiﬁed in the I-helix, the K helix
and the heme-binding region. However, the amino acid sequences in
two of these motifs have features that are unusual compared to
most other animal CYPs. Thus, the I-helix signature of zebraﬁsh
CYP20A1 (aa 276–281, AGCVIT) diverges at the fourth and ﬁfth posi-
tions, notably lacking the usually conserved Thr at the ﬁfth position,
which is involved in the protonation of oxygen during the P450 cata-
lytic cycle (Sezutsu et al., 2013). The heme-binding region of the
zebraﬁsh CYP20A1 (aa 403–411, FSGSQACPE) is one residue shorter
than in most P450s, and displays an unusual sequence around the
conserved Cys that serves as the apical heme iron ligand. Similar
divergence from typical P450 motifs is seen in the I-helix and heme
binding peptide of human CYP20A1.
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The amino acid sequences of the cloned zebraﬁsh and human
CYP20A1s also were aligned with the CYP20A1s of selected other
vertebrate species, gleaned from genome databases (Supplemental
Fig. S1). This alignment showed the presence of a conserved N-terminal
segment and the unusual sequence features of the I-helix and the heme
binding motifs in these other species, similar to those in zebraﬁsh and
human. Note that in human, rodent and chicken there is a second EXXR
motif (EQLR) just upstream of EVTR. However, the EVTR motif identiﬁed
in Fig. 1 is identical in allﬁve CYP20A1 sequences aligned in Supplemental
Figure S2, and aligns with EXXR motifs in helix K of other P450s.
We compared the amino acid sequences of the three signature mo-
tifs in zebraﬁsh CYP20A1 to those in other zebraﬁsh CYP families
(Table 1). Divergence at the fourth and ﬁfth positions of the I-helix
motif like that in CYP20A1 appears as well in CYP7A1 (cholesterol 7α-
hydroxylase), CYP8A1 (prostacyclin synthase), CYP8B1 (sterol 12α-
hydroxylase), and several related zebraﬁsh orphan CYPs (i.e., CYP7C1,
CYP8B2 and CYP8B3), as well as CYP39A1 (oxysterol 7α-hydroxylase).
Thus, the fourth position of the I-helix motif in all of these P450s has a
hydrophobic rather than an acidic residue, and the ﬁfth position does
not contain a Thr residue. Instead, an Asp residue is found in all of the
above-mentioned CYPs except CYP20A1 (which has an Ile residue).
Most of these other CYPs do have a Thr at the 6th position, raising a
question about whether that Thr might fulﬁll a role in proton transfer
to the oxygen. However, CYP8A1 and CYP39A1 do not have a Thr at ei-
ther the 5th or the 6th positions.
Divergence fromthe classicalmotif of theheme-binding regionwasalso
identiﬁed for CYP7A1, CYP8A1, CYP8B1, CYP39A1 (Table 1), and the related
CYP7 and CYP8 orphans. However, these sequences were not identical to
that seen in CYP20A1, which has a unique heme-binding region. Thus,
among zebraﬁsh P450s, CYP20A1 is the only isoform with one residue
missing at the beginning of themotif, a glutamine (neutral residue) instead
of a basic residue at the center of themotif, and a glutamic acid instead of a
glycine (non polar residue) at the terminal position. The same features
distinguish the CYP20A1 from other P450s in human.
3.3. CYP20A1 heterologous protein expression
Zebraﬁsh CYP20A1 was heterologously expressed in E. coli to deter-
minewhether a proteinwith a native P450 spectrum could be obtained,
given the unusual sequence features. A reduced CO-difference spectrum
typical of P450 was obtained (Fig. 2), which indicates expression of
native protein. The presence of a peak at 420 nm in the CO-difference
spectrum indicates partial loss of the cysteine thiolate linkage to the
heme, which is sometimes the result of protein misfolding of non-
native (heterologous) proteins in E. coli. However, we also observed
that the 450 nm peak was rapidly converted to 420 nm, which suggests
that the ferrous–CO complex is unstable, a condition observed with
prostacyclin synthase (CYP8A1), an enzyme that acts on substrates
that carry their own oxygen (Yeh et al., 2005). We did examine the
expressed protein for Type-1 (substrate) binding spectra with choles-
terol and arachidonic acid, but these preliminary studies failed to detect
any binding to recombinant zebraﬁsh CYP20A1 (authors' unpublished
information).
Fig. 1.Alignment of zebraﬁsh and human CYP20A1 proteins: Locations of P450 signaturemotifs and predicted secondary structure are illustrated. Yellow boxes identify alpha-helices and
blue boxes β-strands. Green line locates the position of the predicted transmembrane region, and dashed purple line that of a putative signaling peptide suggested to target the protein to
mitochondria.
Fig. 2. Reduced, CO-difference spectrum of heterologously expressed zebraﬁsh CYP20A1:
Zebraﬁsh CYP20A1 was expressed in E. coli cells after N-terminal modiﬁcation. The
reduced difference spectrum shows a peak at 450 nm, as expected, as well as a peak at
420 nm indicating partial loss of the cysteine thiolate linkage to the heme, possibly due
to the non-native protein expression in E. coli.
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3.4. Tissue distribution and developmental expression of CYP20A1
Real-time quantitative PCR (qPCR) analysis was used to determine
levels of CYP20A1 transcript in organs from male and female zebraﬁsh.
Two sets of samples were analyzed, with tissues pooled from multiple
individuals. In the ﬁrst set, both males and females were examined.
In females, there was a signiﬁcantly higher level of expression in
the ovary and heart than the liver, intestine, kidney, brain and eye
(Fig. 3A). In corresponding male samples, transcript levels in testis
were higher than in the other tissues examined, and levels of expression
were lower in the heart and eye than in the liver or brain (Fig. 3B). In the
second set, we examined the organs from the male only. Expression
levelswere compared indifferent parts of the brain (forebrain,midbrain
and hindbrain), optic nerve, spleen and liver. CYP20A1 transcript was
slightly more abundant in the spleen and optic nerve than in the other
tissues (Fig. 3C).
Earlier we had reported on the levels of most CYP transcripts during
zebraﬁsh development, covering the period from 3 to 48 hpf
(Goldstone et al., 2010). However, the levels of CYP20A1were not read-
ily discernible in the ﬁgures in that report. Values for CYP20A1were ex-
tracted from the previous microarray data, showing that CYP20A1
transcript was more abundant in embryos during the segmentation pe-
riod (12–24 hpf) (Supplemental Fig. S3).
3.5. Reponses to chemical treatment
Possible effects on CYP20A1 expression were assessed in zebraﬁsh
embryos that had been exposed to agonists for selected nuclear
and xenobiotic receptors. Emphasis was put on agonists for recep-
tors involved in steroid function (androgen, estrogen and glucocor-
ticoid receptors — AR, ER, and GR respectively), cholesterol and lipid
metabolism (liver X, farnesoid X and peroxisome-proliferator-
activated receptors - LXR, FXR, and PPAR respectively), response to
xenobiotics (pregnane X receptor, PXR, and the aryl hydrocarbon
receptor, AHR), and morphogenesis (retinoic acid receptor RAR)
(see Supplemental Table S2). Dose–response studies with these
chemicals were conducted in zebraﬁsh embryos with exposure be-
ginning at 24 hpf, and sampling at 48 or 72 hpf (i.e., exposure for
24 or 48 h). Signiﬁcant but modest increases of transcript abun-
dance (about 150% of solvent controls) were observed in embryos
exposed for 48 h to 1 μM of diethylstilbestrol (Fig. 4A), a known
ER agonist in zebraﬁsh, or T0901317 (Fig. 4B), a known LXR–FXR ag-
onist in zebraﬁsh. At the highest dose, farnesol isomers (FXR ago-
nists in zebraﬁsh) and pregnenolone (PXR agonist in zebraﬁsh)
also led to a mild increase (i.e., about 30%) of CYP20A1 mRNA con-
tent in embryos (48 h exposure) (Fig. 4B). A similar increase was de-
tected in embryos exposed to 1 μM dexamethasone (Fig. 4A), a GR
agonist in zebraﬁsh. Slight yet signiﬁcant increases of expression
(i.e., 10–20%) were also observed with 10 μM of docosahexaenoic
acid (24 h exposure) (Supplemental Table S3), a PPAR agonist in
zebraﬁsh, 1 μM of pregnenolone and 3.2 μM of the AR agonist andro-
stenedione (48 h exposures) (Fig. 4). Expression of CYP20A1
decreased by about 10–20% in embryos exposed to doses up to
3.2 μM all-trans retinoic acid (24 h exposures) (Supplemental
Table S3), a RAR agonist in zebraﬁsh. (At 10 μM, all-trans retinoic
acid treatment resulted in 98% mortality.)
Fig. 3. Expression of CYP20A1 transcript in zebraﬁsh tissues: For both sexes, transcript levelsweremeasured by real-time quantitative PCR (qPCR) using a double reference gene approach
(elongation factor 1α and aryl hydrocarbon receptor nuclear translocator 2), and data are expressed relative (i.e., fold change) to transcript content in liver. Pools of organswere prepared
and qPCRwas run on three pools each for females (Fig. 3A) andmales (Fig. 3B). In the second set, qPCRwas run on three pools frommales only (Fig. 3C). Data are presented asmean± SD.
Different letters indicate signiﬁcant difference of expression in organs of males and females separately (Kruskal–Wallis ANOVA with post-hoc Z-adjusted Mann–Whitney U test).
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We also examined the response to the non-ortho-substituted (dioxin-
like) polychlorinated biphenyl (PCB) 126, an AHR agonist (Supplemental
Table S2). Exposureswere for 48 h, from24 to 72 hpf. Nanomolar doses of
PCB 126, which are highly effective at inducing the target gene CYP1A in
zebraﬁsh (Jonsson et al., 2007b), did not elicit any change in CYP20A1
expression (not shown).
To assess further the possible involvement of nuclear receptors and
other transcription factors (TFs) in the regulation of CYP20A1 ex-
pression, we used an in silico search to predict putative TF binding
sites. A 10 kb proximal promoter region of the zebraﬁsh and human
CYP20A1 genes was examined, along with the promoters of CYP20A1
predicted in genomes of several other vertebrate species (rat, chicken,
frog). We screened these regions for the presence of possible binding
sites (i.e., response elements) for nuclear and xenobiotic receptors.
When restricting the search to putative binding sites exactly matching
thehuman core sequences, severalwere found to occur in proximal pro-
moters of all the vertebrate CYP20A1 genes examined. These response
elements are for the vertebrate steroidogenic factor 1 (SF1), the estro-
gen receptors and estrogen-related receptors (ERs and ERRs), the
retinoic acid receptor-related orphan receptor alpha (RORα), the perox-
isome proliferator-activated receptors (PPARs) and glucocorticoid re-
ceptor (GR) (Table 2). When a less stringent cut-off of core sequence
similarity was applied (i.e., 80%), response elements were identiﬁed
also for other nuclear receptors. These include the androgen receptor
(AR), the progesterone receptor (PR), the farnesoid X receptor (FXR),
the hepatocyte nuclear factor 4 (HNF4) and the retinoid receptors
(RAR and retinoid X receptor — RXR) (Supplemental Table S4). At 70%
core sequence identity, binding sites were identiﬁed for the liver X re-
ceptor (LXR) but not AHR (data not shown).
Proximal promoter analyses also identiﬁed putative binding sites for
numerous TFs that were not nuclear or xenobiotic receptors. Gene
ontology terms were compiled from the Uniprot database (Bairoch
et al., 2005) for these recurring TFs, and keyword searches conducted
to determine the proportion of TFs putatively involved in CYP20A1
regulation that were associated with a particular cell type, biological
system or process. At 100% core sequence identity, TFs active in the
brain, blood cells (amongwhich 77%were notably involved in immunity;
data not shown), skeletal system, eye, sensory system, germ cells and
stem cells were over-represented, as were TFs involved in neurogenesis,
cell migration, neurulation and anterior/posterior patterning. Wingless
(Wnt), Smoothened and Notch were the major developmental signaling
pathways represented (Supplemental Table S5). Similar observations
(i.e., enrichment of ontology terms) were made at 80% core sequence
identity (data not shown).
To assess the inﬂuence of environmental toxicants on CYP20A1
expression, we examined zebraﬁsh embryos exposed to MeHg chloride
(10 and 50 μg·l−1) from 24 and 48 hpf (Hassan et al., 2012). The MeHg
elicited dose-dependent reduction in CYP20A1mRNA levels in zebraﬁsh
embryos (Fig. 5). With the higher dose tested, CYP20A1 transcript
abundance was less than half the level in solvent controls, and was
signiﬁcantly lower than the levels obtained with a 10 μg·l−1 dose
(p = 0.048; not shown).
3.6. Knockdown of CYP20A1 and phenotypic effects
To gain insight into the function of CYP20A1 protein in zebraﬁsh, we
used a morpholino (MO) gene knockdown approach. Morpholinos
targeted to the CYP20A1 translation start site, which inhibits CYP20A1
protein synthesis, were injected into 2- to 4-cell stage embryos
and morphological and behavioral phenotypes screened at various
times. In these studies we used two approaches, with different strains,
for assessing morphological and behavioral effects of MO treatment.
With TL zebraﬁsh, morphology was assessed daily, and no obvious ef-
fects were seen in ﬁsh that were uninjected, control MO-injected or
CYP20A1 MO-injected. Morphology was examined also in a high-
throughput analysis using the Tropical 5Dwild-type strain. In those lat-
ter analyses embryos injected with coded CYP20A1 or control MOs, and
non-injected controls, were examined in a blind test at 24 hpf and at
5 days post-fertilization (dpf). At 24 hpf, somites and notochord ap-
peared normal in both control MO and CYP20A1MO embryos. Viability
Fig. 4. Expression of CYP20A1 in zebraﬁsh embryos exposed to agonists for nuclear receptors: (A) Responses to diethylstilbestrol (black), androstenedione (white), and dexamethasone
(grey). (B) Responses to T0901317 (black), farnesol isomers (white), and 5-pregnen-3β-ol-20-one (grey). Transcript levels were measured by real-time quantitative PCR (qPCR) using a
double reference gene approach (elongation factor 1α and aryl hydrocarbon receptor nuclear translocator 2). Exposures were from 24 to 72 h post-fertilization on pools of 15 embryos in
60ml of 0.3×Danieau's solutionwith 0.1%of dimethylsulfoxide as carrier. Resultswere expressed as fold change from results obtainedwith carrier alone. Data are presented asmean±SD
of 4 replicates. Since the various doses of each chemical were tested in separate experiments, analyseswere conductedwith a 2-tailed Student's t-test. Asterisks indicate levels of statistical
signiﬁcance (* for p ≤ 0.05; ** for p ≤ 0.01).
Table 2
Recurring putative binding sites for families of nuclear receptors in proximal promoters of CYP20A1s in vertebrates.
Matrix family Danio rerio Xenopus tropicalis Gallus gallus Rattus norvegicus Homo sapiens
Steroidogenic Factor (V$SF1F) 2 11 9 6 6
Estrogen Response (V$EREF) 3 5 8 7 2
v-ERB and RAR-related Orphan Receptor Alpha (V$RORA) 3 5 5 7 13
Peroxisome Proliferator-activated Receptor (V$PERO) 6 22 14 9 13
Glucocorticoid Response and Related (V$GREF) 8 12 14 14 7
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was unaffected, however, CYP20A1 MO-injected embryos exhibited a
delayed development (data not shown). There were no morphological
abnormalities noticed at 5 dpf in either the control MO or the CYP20A1
MO groups, i.e., yolk sac, body axis, eye, snout, jaw, otic vesicle, heart,
brain, ﬁns, trunk, swim bladder, notochord, pigmentation and circula-
tion appeared normal.
We examined behavioral effects of CYP20A1 knockdown in a blind
test at an early stage of development, 24 hpf. For this assay, we
employed the Tropical 5D strain injected with coded CYP20A1 MO or
control MO as above, and movement (tail ﬂexion) was examined in
ovo (Truong et al., 2014). Analysis revealed a greater in ovo activity in
the CYP20A1MO treated embryos, in both the dark-baseline and light-
excitatory phases (Fig. 6).
For later stage behavioral studies, TL strain zebraﬁsh (the strain from
whichCYP20A1had been cloned)were injectedwith control or CYP20A1
MOs at the 2- to 4-cell stages and at 5 dpf were screened for an
optomotor response, and for locomotory activity with an automated
tracking system. Non-injected TL zebraﬁsh embryos were similarly
tested.
We ﬁrst tested for the optomotor response (OMR), a test for visual
responsiveness in which ﬁsh larvae follow waves of vertical black and
white stripes displayed on the ﬁsh tank bottom. Larvae from the three
experimental groups were tested individually over 1-min periods, and
the distance they travelled was recorded every 15 s. On average, larvae
in the CYP20A1MO group travelled about 20% less distance than those
injectedwith controlMO, or not injected (Fig. 7A). A substantial number
of larvae in the CYP20A1 MO group did not initiate an oriented move-
ment after 15 or 30 s of stimulation, indicating latency or reduced
responsiveness of these ﬁsh to the visual stimulus. The CYP20A1 MO
treatment did not appear to affect the locomotory capacity of larvae
that did respond to the stimulus, based on distances travelled per unit
time once the response began.
We then investigated the spontaneous locomotory behavior of
CYP20A1 MO-injected TL larvae, using an automated tracking system
(Viewpoint Zebrabox). In three independent experiments, eight larvae
from each group (CYP20A1 MO-injected, control MO-injected and,
non-injected) were tested simultaneously in 24-well plates, under con-
stant illumination. Two 10-min movies were recorded, one for tracking
movement (locomotion or directed motion) and the other for “activity
quantitation”, quantitation of general activity. In the directed motion
assay, CYP20A1 MO-injected larvae spent signiﬁcantly more time
at high speed (≥0.5 cm·s−1) than either non-injected or control
MO-injected larvae, and also travelled more distance at high speed
(Fig. 7B). Hyperactivity or bursts of activity, evident as signiﬁcantly lon-
ger periods of time they spent at a high activity state, were typical of
these larvae. This was reﬂected also in the higher level of total activity,
expressed as integrated values (Fig. 7C).
4. Discussion
In these studies, we cloned and sequenced the cDNA of CYP20A1 of
the zebraﬁsh TL strain and found it identical to the zebraﬁsh CYP20A1
coding sequence available in databases, and with a high % identity to
the cloned human CYP20A1. Unusual features of the CYP20A1 sequence
have been suggested before, based largely on inferences from genome
sequences (Sezutsu et al., 2013). The comparison of cloned zebraﬁsh
and human CYP20A1s establishes that these unusual features are pres-
ent in the expressed proteins from both species. Zebraﬁsh and human
CYP20A1s have a highly conserved N-terminal motif that not only con-
tains the transmembrane domain typical of microsomal P450s, but also
have an adjacentmotif that could possibly act as a signal peptide formi-
tochondrial targeting. This suggests that CYP20A1smight have a bimod-
al distribution in the ER and mitochondria, similarly to some other
vertebrate P450s (Avadhani et al., 2011). Further work is needed to de-
termine whether there is dual subcellular localization of CYP20A1s.
The zebraﬁsh CYP20A1 protein and the human ortholog contain a
typical EXXR motif in the K-helix, thought to be required for proper
folding and heme inclusion (Sezutsu et al., 2013). However, the I-helix
and heme-binding regions were found to diverge signiﬁcantly from
the classical P450 signaturemotifs. The absence of one residue at the be-
ginning of the heme-binding motif, and the Glu instead of a conserved
Gly at the terminal portion, are unique to CYP20A1 when compared to
other vertebrate P450s. Replacement of a non-polar (Gly) by a negative-
ly charged (Glu) residue at the end of the heme-bindingmotif is intrigu-
ing considering that the sitewhere this change occurs is thought to be in
close vicinity to the catalytic Cys in the tertiary structure (Otyepka et al.,
2007). The presence of a Gln residue at a central site of the heme-
binding motif, where usually an Arg or His residue is found, is also
intriguing. The signature Arg or His residue is responsible for the hydro-
gen bonding with one heme propionate (Otyepka et al., 2007). It has
been suggested that these hydrogen bonds not only can inﬂuence the
Fig. 5. Expression of CYP20A1 in zebraﬁsh embryos exposed to methylmercury chloride:
Transcript levels were measured by real-time quantitative PCR (qPCR) using a double
reference gene approach (elongation factor 1 α and aryl hydrocarbon receptor nuclear
translocator 2). Exposures were from 24 to 48 h post-fertilization on pools of 15
embryos in 60 ml of 1× E3 medium with 0.1% of distilled water as carrier. Results are
expressed relative (i.e., fold change) to those obtainedwith carrier alone.Data are present-
ed asmean± SDof 4 replicates. Analysis of the difference inCYP20A1 expression from sol-
vent controls was conducted with one-way ANOVA followed by post hoc LSD Fisher's test.
Asterisks indicate levels of statistical signiﬁcance (* for p ≤ 0.05; ** for p ≤ 0.01).
Fig. 6. In ovo tail ﬂexion movement response in zebraﬁsh embryos treated with CYP20A1
morpholino: In ovo tail ﬂexion movement was automatically analyzed at 24 h post-
fertilization in zebraﬁsh embryos of the Tropical 5D wild-type strain after injection with
CYP20A1 morpholino (MO A) (top line) or control morpholino (MO B). Embryos that
were not injected (Uninj) were also used in the blind test. Individuals were placed one
per well of a 96-well plate. The red vertical lines indicate the time of a single bright,
visible ﬂashlight. The Y-axis values (Movement) are an index of tail ﬂexion (i.e., pixel
changes between successive frames), and the X-axis values are given in seconds. Asterisks
and labels indicate the statistically signiﬁcant hyperactivity associated with CYP20A1
morpholino in both the baseline (dark, un-stimulated) phase and in theﬁrst excitatory pe-
riod (i.e., following ﬁrst pulse of bright light), andwith control morpholino in just the ﬁrst
excitatory period.
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stability of heme proteins, but also their reactivity and ligand selection
(Ramos-Santana and Lopez-Garriga, 2012). Note that Gln is also able
to generate a hydrogen bondwith the heme propionate. These features
imply there could be unusual catalytic properties of CYP20A1s, as previ-
ously suggested (Sezutsu et al., 2013). In preliminary studies we failed
to detect any binding of cholesterol or arachidonic acid to recombinant
zebraﬁshCYP20A1. Likewise, Stark et al. (2008) did not detect any activ-
ity of human CYP20A1 with cholesterol or arachidonic acid or any of 9
other possible substrates, including neurotransmitters. However, in a
proteomic mapping of cholesterol-interacting proteins CYP20A1 was
identiﬁed as possibly interacting with a trans-sterol probe (Hulce
et al., 2013). The success at expressing recombinant zebraﬁsh
CYP20A1 will facilitate the search for substrates, and could provide a
platform to test possible functions.
The divergence observed in the I-helix, especially the absence of the
conserved threonine at the 5th position of themotif, is similar towhat is
observed in zebraﬁsh and human CYP7s and CYP8s. In most cases these
sequences differ from zebraﬁsh CYP20A1 in having a Ser residue at the
second position of the motif (although a Ser is present in human
CYP20A1), a Gly residue at the fourth and an Asn residue at the ﬁfth po-
sition. While the functional signiﬁcance of these I-helix features of
CYP20A1 is unknown, it is notable that the presence of an Ile residue
rather than Thr at the 5th position of the I-helix motif also occurs in
human CYP5A1 (thromboxane synthase). Reverse-engineering experi-
ments with human CYP5A1 have demonstrated a speciﬁc role for the
Ile residue in keeping rates of product formation by the enzyme at low
levels (Meling et al., 2015). The tight control of catalysis by CYP5A1 sug-
gests that the Ile in CYP20A1 could perhaps act similarly to limit product
formation by this enzyme. Thus, too much or too little CYP20A1 activity
could be detrimental.
4.1. Tissue distribution in reproductive, immune and nervous systems
The tissue distribution of CYP20A1 transcript in zebraﬁsh was some-
what different from that observed with rodents. Thus, in male mouse,
abundant CYP20A1 expression was found in the spleen, followed by the
skeletal muscle, brain, heart, lung, kidney, testis and liver (Choudhary
et al., 2003). In male rat, CYP20A1 was most strongly expressed in the
liver, followed by the lung, spleen, kidney, heart, brain and testis
(Takiguchi et al., 2010). Regardless of these differences, studies
with zebraﬁsh, human (Stark et al., 2008) and rodents are consistent in
pointing to relatively high-level expression for CYP20A1 in reproductive,
immune andnervous tissues. These patterns are consistentwith the puta-
tive TF binding sites in CYP20A1 proximal promoters.
The tissue distribution in zebraﬁsh brain and eye also suggests a role
for CYP20A1 in development and maintenance and/or function of the
nervous system, supporting the inference from high level expression
in human hippocampus, substantia nigra and retinal pigment epitheli-
um (Stark et al., 2008; Strunnikova et al., 2010). It also has been noted
that traumatic injury to both hippocampus and retinal pigment epithe-
lium resulted in signiﬁcant up-regulation of CYP20A1 expression in
these rodent tissues (Birnie et al., 2013; Hadziahmetovic et al., 2012).
Our observation that the optomotor response was slowed in the MO
knockdown larvae is consistent with some role in visual processes.
Reﬁning the localization of CYP20A1 expression in zebraﬁsh brain is an
objective for further studies.
Fig. 7.Optomotor and locomotory effects of CYP20A1 knockdown in zebraﬁsh larvae: TL embryos were injected at the two-to-four cell stage with amorpholino (MO) speciﬁc for CYP20A1
or a control morpholino (Ctrl MO). Batch-speciﬁc embryos that were not injected were also used (Non-injected). Assays were conducted on 5 day-old ﬁsh. In the optomotor response
study (OMR; Fig. 7A), a sine wave of black and white stripes (6.5 cm periodicity; 0.5 Hz) was tested (20 larvae per replicate per group; tested individually) and the sum of the straight
distances travelled was used to compare OMR between groups every 15 s, up to 1 min. Upper and lower panels show results from the ﬁrst time bins as percentages of the straight
distance travelled relative to non-injected larvae. The automated ViewPoint Zebrabox® was used to track locomotion (Fig. 7B) and activity (Fig. 7C) of the larvae in 24-well plates
under constant illumination. 8 larvae from each group were simultaneously tested in consecutive 10-min movie sessions (one for movement tracking and one for activity
quantitation). For movement tracking, thresholds were: 0.5 cm·s−1 for large and 0.1 for no movement. Upper and lower panels of Fig. 7B respectively depict the time and distance
travelled by larvae at high speed (i.e., ≥0.5 cm·s−1). For activity quantitation, thresholds were: 10 pixels per frame for burst and one for freeze. Upper and lower panels of Fig. 7C respec-
tively depict the time spent by larvae in a hyperactive state (i.e., ≥10 pixels per frame) and their total level of activity (i.e., area under curve). Data are presented as mean ± SEM of six
replicates for OMR and three replicates for tracking and activity, and were analyzed with Kruskal–Wallis ANOVA followed by Z-adjusted Mann–Whitney U test (OMR) or one-way
ANOVA followed by post hoc LSD Fisher's test (tracking-and-activity). Differences of CYP20A1MO groups from non-injected controls are indicated by asterisks, (* p ≤ 0.05; ** p ≤ 0.01)
and from Ctrl MO by diamonds (♦ p ≤ 0.05; ♦♦ p ≤ 0.01).
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The data on CYP20A1 expression in the literature also reveal an en-
richment of the transcript in human neural progenitor cells derived
from embryonic stem cells (Chan et al., 2015) and expression, along
with a limited set of other CYP genes, in human cord blood hemato-
poietic and early progenitor cells (Xu et al., 2014) These observations
support a role for CYP20A1 at early stages of cell differentiation in
some tissues.
4.2. Response to agonists for nuclear and xenobiotic receptors
At micromolar doses, agonists for some nuclear receptors modestly,
but signiﬁcantly, increased CYP20A1 transcript levels in zebraﬁsh em-
bryos. The responses conform to predictions based on the presence of
cis-response elements in the proximal promoter region of CYP20A1s.
In silico and in vivo studies point to regulation of CYP20A1 expression
by nuclear receptors involved in steroid response, cholesterol and lipid
metabolism, and down-regulation by the morphogen all-trans retinoic
acid.
Among NR agonists, the highest increases of CYP20A1 expression
were seen with diethylstilbestrol (DES) and T0901317. In zebraﬁsh,
DES is a potent ER agonist (Gorelick and Halpern, 2011). In mammals,
it also acts as an inverse agonist for ERRs (Coward et al., 2001). To our
knowledge, there are no reports of antagonism of zebraﬁsh ERRs by
DES. However, putative binding sites were speciﬁcally predicted for
ERRα in proximal promoters of the vertebrate CYP20A1s at a cut-off of
80% of the human core sequence identity. ERs exert functions in repro-
duction and neuronal protection (Dahlman-Wright et al., 2006), while
ERRs control the diurnal expression of genes involved in fatty acid, cho-
lesterol and bile acid metabolism (Giguere et al., 2011).
An increase of CYP20A1 expression in zebraﬁsh embryos also was
observed with T0901317 exposure. T0901317 is a benzenesulfonamide
that is a potent agonist for LXR in mammals, and also is an agonist for
PXR and FXR (Houck et al., 2004; Mitro et al., 2007) and an inverse ag-
onist for RORα, and RORγ (Kumar et al., 2010). T0901317 appears to be
an agonist for zebraﬁsh LXR and FXR, but not PXR (Krasowski et al.,
2011; Reschly et al., 2008). In silico studies predicts the presence of
binding sites for FXR and RORα in promoters of vertebrate CYP20A1. A
less stringent cut-off also identiﬁed binding sites for LXR (i.e., 70% sim-
ilarity with human set of LXR binding sites). These observations suggest
that a diversity of nuclear receptors could have been involved in the
T0901317-mediated increase of CYP20A1 expression. The LXRs and
FXR are involved in sterol and bile acid homeostasis (Kalaany and
Mangelsdorf, 2006), while RORs,which bind cholesterol, exert functions
in the brain and eye development, and immunity (Jetten, 2009). In con-
trast, there was no effect on CYP20A1 expression by nanomolar doses of
PCB 126, or 2,3,7,8-tetrachlorodibenzo-p-dioxin (data not shown),
pointing to a lack of involvement of the AHR. Immunoassay with anti-
bodies to zebraﬁsh CYP20A1would help to deﬁne localization of protein
and responses to chemical treatment.
4.3. CYP20A1 knockdown effects
The potential involvement of CYP20A1 in neurobehavioral disorders
is indicated not only by the expression in zebraﬁsh, rodent and human
brain, but also by the effects of CYP20A1 knockdown investigated here.
Zebraﬁsh embryos in which CYP20A1 translation was partly inhibited
showed developmental delay at 24 hpf, and behavioral effects were ev-
ident at 1 and 5 dpf. The latency in initiating an appropriate swimming
response due to CYP20A1knockdown in theOMRassay can be described
as a defective visuo-motor integration or coordination, or an increased
anxiety (Kalueff et al., 2014), rather than an impaired locomotory ca-
pacity. Larvae of the CYP20A1MO group also exhibited a substantial in-
crease of activity and swimming speed compared to the two control
groups in the automated tracking-and-activity experiments. The possi-
bility that the conﬁned settings of the multiwell plates elicited these
phenotypes in the CYP20A1 knockdown ﬁsh cannot be ruled out; thus,
these bursts of activity and higher swimming speeds could have been
driven by anxiety (Maximino et al., 2010).
Intriguingly, these phenotypic effects of CYP20A1 knockdown in
zebraﬁsh are strongly reminiscent of those seen in humanpatients diag-
nosed with microdeletions in the 2q33 chromosome region where
CYP20A1 is located. Patients with this rare syndrome variously show
psychomotor retardation, hyperactivity and bouts of anxiety, and a
delayed visuomotor coordination was speciﬁcally reported once
(Balasubramanian et al., 2011; Tomaszewska et al., 2013). Analyzing
the speciﬁc regions deleted, which are displayed in Balasubramian
et al. (Balasubramanian et al., 2011), reveals that the majority of pa-
tients (5–6 of 7) with deletions that included CYP20A1 presented
with hyperactivity, while this phenotype was rarely observed in pa-
tients with deletions that excluded CYP20A1 (1–3 of 13). The pres-
ent results with knockdown of CYP20A1 in zebraﬁsh, and the 2q33
microdeletion patients, suggests that this orphan P450 could well
be involved in neurobehavioral hyperactivity.
4.4. Response to methylmercury
The possible effects of a neurotoxicant on CYP20A1 expression were
assessed by exposing zebraﬁsh embryos toMeHg, among the chemicals
suggested to contribute to hyperactivity disorder (Grandjean and
Landrigan, 2014). These experiments revealed a dose-dependent reduc-
tion of CYP20A1 transcript abundance following 24 h exposure of
zebraﬁsh, beginning at 24 hpf. The higher dose tested resulted in the
strongest decline of CYP20A1 expression. Notably, theMeHg concentra-
tion threshold in human cord blood that is associatedwith the detection
of behaviors typical of attention deﬁcit hyperactivity disorder (ADHD)
during childhood is very close to the lowest dose we tested (Boucher
et al., 2012). Providing that this effect on CYP20A1 expression also
occurs in human and translates into changes at the protein level, it
is tempting to envisage a link between prenatal exposure to MeHg,
CYP20A1 repression (with detrimental developmental consequences)
and the onset of ADHD. We are investigating further the mechanism
of the MeHg effect on CYP20A1, and how CYP20A1 may function in
neurological processes. Such studies will include direct comparison of
behavioral change and CYP20A1 expression followingMeHg exposures,
as well as CYP20A1 responses to other neurotoxicants.
5. Conclusion
In this study,we cloned and examined properties of the zebraﬁsh or-
phan P450 CYP20A1. Peculiar structural features of zebraﬁsh, human
and other vertebrate CYP20A1s are clues to an unusual catalytic
function. The expression patterns of CYP20A1 transcript, and putative
transcription factor binding sites suggest potential involvement in re-
productive, immuneandneuronal functions, aswell as steroid response,
lipid and cholesterol metabolism. A possible involvement in neuronal
processes is strongly indicated by the behavioral effects occurring in
zebraﬁsh larvae treated with amorpholino against CYP20A1. The effects
of knockdown – especially hyperactivity – are reminiscent of those in
humans who have a microdeletion that includes loss of CYP20A1 gene.
The MeHg-mediated reduction of CYP20A1 transcript levels in zebraﬁsh
embryos points to the possibility that disruption of CYP20A1 expression
may be involved in someneurobehavioral disorders. Studies of CYP20A1
expression with additional toxicants are underway. Future studies will
investigate whether over-expression can reverse behavioral deﬁcits
seen with MO treatments or MeHg, or whether overexpression also
could be detrimental, which could occur if tight regulation of the en-
zyme might be necessary. The results presented here together shed
new light on the possible biological and toxicological signiﬁcance of
the orphan CYP20A1 that has thus far resisted “deorphanization”.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.taap.2016.02.001.
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